2,3-butylene glycol has been researched along with Coronary Disease in 1 studies
2,3-butylene glycol: RN given refers to cpd without isomeric designation
butane-2,3-diol : A butanediol in which hydroxylation is at C-2 and C-3.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heer, KR | 1 |
| Althaus, U | 1 |
| Mettler, D | 1 |
| Schilt, W | 1 |
| Thoelen, H | 1 |
1 other study available for 2,3-butylene glycol and Coronary Disease
| Article | Year |
|---|---|
2,3-butanediol in experimental myocardial ischaemia in pigs.
Topics: Animals; Butylene Glycols; Coronary Disease; Coronary Vessels; Ischemia; Lactates; Lactic Acid; Myoc | 1991 |